Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy

Completed · Phase 1

Conditions studied: Prostate Cancer

In brief

RATIONALE: High doses of testosterone may be effective in killing prostate cancer cells that no longer respond to hormone therapy. PURPOSE: Phase I trial to study the effectiveness of testosterone in treating patients who have progressive prostate cancer that no longer responds to hormone therapy.

Key facts

Study ID

NCT00006044

Run by

Memorial Sloan Kettering Cancer Center

Starts

2000-02-01

Last updated by the study team

2013-01-18

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.